Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2011 A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Long Term Safety of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain GlaxoSmithKline Principal Investigator
2. 2011 A Multicenter Randomized, Double-blind, Controlled Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Two Capsaicin Concentration Variations of NGX-1998 (10% or 20% w/w) in Subjects With Postherpetic Neuralgia (PHN). NeurogesX, Inc Principal Investigator
3. 2011 A 12-Week, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BEMA® Buprenorphine in Subjects With Moderate to Severe Low Back Pain BioDelivery Sciences International, Inc Principal Investigator
4. 2011 A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study to Evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5, 1, 3, 6, or 12 mg by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniatio Cephalon Co-Investigator
5. 2011 A confirmatory, placebo-controlled, randomized, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio with an improved bowel function and a comparable analgesic efficacy compared to hydromorphone alone. Mundipharma Research GmbH & Co Principal Investigator
6. 2011 A 12-Month, Open-Label Extention Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 15 to 90 mg Twice a Day in Patients Who Require Opioid Treatment for Extended Periods of Time. Cephalon Co-Investigator
7. 2011 A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Relief of Moderate to Severe Pain in Patients Who Require Opioid Treatment for an Extended Period of Time Cephalon Co-Investigator
8. 2011 A Phase IIa, Double-Blind, Randomised, Parallel-Group, Multi-Centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2066 with One-Dose Escalation Compared to Placebo in Peripheral Neuropathic Pain Patients with Mechanical Hypersensitivity AstraZeneca Principal Investigator
9. 2011 A Prospective, Randomized, Double-Blind, Cross-Over, Multi-Center Study to Evaluate the Comparative Efficacy of Pulsed-Radiofrequency Neuromodulation of the Dorsal Root Ganglion Versus Transforaminal Lumbar Epidural Steroid Injection for the Treatment of Chronic Radicular Low Back Pain Millennium Pain Center, Bloomington, Illinois; Teknon Foundation, Barcelona, Spain Co-Investigator
10. 2011 A Multicenter, Randomized, Blinded, Saline-Controlled Trial of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) with the Biostat® System. Spinal Restoration, Inc Co-Investigator
11. 2011 Spinal Cord Stimulation with Precision® SCS System versus Reoperation, EVIDENCE Boston Scientific Principal Investigator
12. 2011 A Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Response Study of Gabapentin Injection for Intrathecal Administration in Subjects with Chronic, Intractable Pain Medtronic, Minneapolis, Minnesota Principal Investigator
13. 2011 A Multi-Center, Prospective, Randomized, Controlled, Single-Blind Evaluation of the Safety and Efficacy of Percutaneous Lumbar Epidural Adhesiolysis in the Treatment of Painful Spinal Stenosis Epimed, Johnstown, New York Principal Investigator
14. 2011 A Phase 3 Randomized, Double-Blind Placebo and Naproxen Controlled Multicenter Study of the Analgesic Efficacy and Safety of Tanezumab in Patients with Osteoarthritis of the Hip or Knee Pfizer Principal Investigator
15. 2011 A Phase 3, Multicenter, Randomized, Long-Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip Pfizer Principal Investigator
16. 2011 Implantable System Performance Registry (ISPR Medtronic Co-Investigator
17. 2011 A Phase 3, Multi-Center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone in Patients with Osteoarthritis of the Knee or Hip. Pfizer Principal Investigator
18. 2011 A Prospective, Randomized, Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Pulsed-Radiofrequency Versus Continuous Radiofrequency Neuromodulation for the Treatment of Chronic Lower Back Pain Originating from Lumbar Facet Joints. Millennium Pain Center, Bloomington, Illinois; Teknon Foundation, Barcelona, Spain Co-Investigator
19. 2011 A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain, Followed by a 12-Week Open-Label Extension to Evaluate the Impact of Fentanyl Buccal Tablets on Patient Outcomes. Cephalon Principal Investigator
20. 2011 Low Back Pain Outcomes Registry (LoBaPOR) Medtronic Co-Investigator
21. 2011 Incidence of Intravascular Penetration During Interlaminar Epidural steroid Injections Millennium Pain Center, Bloomington, Illinois. Principal Investigator
22. 2011 The Nevro Study: Evaluation of Nevro Handheld Stimulator for the Treatment of Back Pain Nevro Corporation Co-Investigator
23. 2011 A 4-Week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain, Cephalon Principal Investigator
24. 2011 A Randomized, Double-Blind, Placebo- and Oxycodone Immediate Release (IR) – Controlled Study of Tapentadol IR for the Treatment of Acute Pain Caused by Vertebral Compression Fractures Associated With Osteoporosis Johnson & Johnson Co-Investigator
25. 2011 A Prospective, Clinical Trial of the Predictive Value of Sympathetic Blocks and Somatosensory Evoked Potential Testing in successful treatment of Chronic Neuropathic Pain with Spinal Cord Stimulators Millennium Pain Center, Bloomington, Illinois Co-Investigator
26. 2011 A Prospective, Randomized, Double-blind controlled Clinical Trial Comparing the Efficacy of Pulse Radiofrequency Lesioning (PRFL) versus Neurolytic Radiofrequency Ablation in the Treatment of Lumbar Facet Syndrome Millennium Pain Center, Bloomington, Illinois Co-Investigator
27. 2011 Spinal Neuromodulation in the Treatment of Chronic Discogenic Low Back Pain Advanced Bionics and Millennium Pain Center Principal Investigator
28. 2011 Analgesia and Paresthesia in Spinal Electrical Neuromodulation: Mechanistic Interaction or Sensory Overlap Advanced Bionics and Millennium Pain Center Principal Investigator
29. 2011 Effectiveness of the Precision Spinal Cord Stimulation System in Patients with FBSS and Axial low Back Pain Advanced Bionics and Millennium Pain Center Principal Investigator
30. 2011 A Multi-Center, Randomizes, Double-Blind, Placebo-Controlled, Parallel-Group Study of MOA-728 in the Treatment of Opioid Induced Constipation in Patients with Non-Malignant Pain Wyeth Principal Investigator
31. 2011 The E-STIM Trial: A Randomized, Double-Blind, Multicenter Trial Comparing the Efficacy of the Empi SelectTM Transcutaneous Electrical Nerve Stimulation (TENS) to a Control for the Treatment of Chronic Lower Back Pain EMPI Principal Investigator
32. 2011 Randomized, Controlled Clinical Study to Evaluate the safety and Effectiveness of Cortoss Synthetic Cortical Bone Void Filler in Vertebral Augmentation, Orthovita Principal Investigator
33. 2011 A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain GlaxoSmithKline Principal Investigator
34. 2011 , A Clinical Evaluation of the Eon™ 16-Channel Implantable Pulse Generator (IPG) in combination with two Octrode® (8 contact) leads for the management of chronic back pain with or without neuropathic leg pain Advanced Neuromodulation Systems, A St. Jude Medical Co Co-Investigator
35. 2011 A Multicenter, Randomized, Placebo-controlled, Double blinded Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid-induced Bowel Dysfunction Covance/Sucampo Co-Investigator
36. 2011 Open-Labeled Study of the Long Term Safety and Efficacy of Lubiprostone in Patients with Opioid-induced Bowel Dysfunction Covance/Sucampo Co-Investigator
37. 2011 A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose, Dose Escalation Study to Evaluate the Efficacy, Safety and Tolerability of NKTR-118 in Patients with Opioid-Induced Constipation (OIC) Nektar/Parexel Principal Investigator
38. 2011 A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients with Osteoarthritis or Rheumatoid Arthritis (MEDAL study). Merck & Co Principal Investigator
39. 2011 A Prospective, Randomized, Double-blind, Multicenter Trial to evaluate Etrocoxib vs. Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness Merck & Co Principal Investigator


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.